Are there differences? SHBG levels, free testosterone and sexual pain in women using combined hormonal contraception: a retrospective study in vulvodynia patients

      It is estimated that more than 2.4 million women in the United States have vulvodynia. Many of these women use contraception containing both estrogen and progestin. Hormonal contraception has been shown to affect serum level of sex hormone-binding globulin (SHBG), a protein binds free testosterone. The goal of this study is to explore the differences and relationships among SHBG levels, serum testosterone and sexual pain in vulvodynia patients using various hormonal contraception regimens.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect